ANP antibody
GTX109255
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityAmphibian, Human, Mammals, Mouse, Rat
TargetNPPA
Overview
- SupplierGeneTex
- Product NameANP antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:1000-1:10000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1.46 mg/ml
- ConjugateUnconjugated
- FormulationLiquid
- Gene ID4878
- Target nameNPPA
- Target descriptionnatriuretic peptide A
- Target synonymsANF; ANP; ATFB6; atrial natriuretic factor prohormone; atrial natriuretic peptide prohormone; atriopeptigen; atriopeptin; ATRST2; cardiodilatin-related peptide; cardionatrin; CDD; CDD-ANF; CDP; natriuretic peptide precursor A variant 1; natriuretic peptides A; PND; preproANP; preproCDD-ANF; prepronatriodilatin; proANF; proANP
- HostRabbit
- IsotypeIgG
- Protein IDP01160
- Protein NameNatriuretic peptides A
- Scientific DescriptionThe protein encoded by this gene belongs to the natriuretic peptide family. Natriuretic peptides are implicated in the control of extracellular fluid volume and electrolyte homeostasis. This protein is synthesized as a large precursor (containing a signal peptide), which is processed to release a peptide from the N-terminus with similarity to vasoactive peptide, cardiodilatin, and another peptide from the C-terminus with natriuretic-diuretic activity. Mutations in this gene have been associated with atrial fibrillation familial type 6. [provided by RefSeq]
- ReactivityAmphibian, Human, Mammals, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Hdac8 Inhibitor Alleviates Transverse Aortic Constriction-Induced Heart Failure in Mice by Downregulating Ace1. Zhao T et al., 2022, Oxid Med Cell LongevRead more
- Neurogenic Hypertension Mediated Mitochondrial Abnormality Leads to Cardiomyopathy: Contribution of UPR(mt) and Norepinephrine-miR- 18a-5p-HIF-1alpha Axis. Nandi SS et al., 2021, Front PhysiolRead more
- Selective HDAC8 Inhibition Attenuates Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis via p38 MAPK Pathway. Zhao T et al., 2021, Front PharmacolRead more
- Pyrroloquinoline quinone attenuates isoproterenol hydrochloride-induced cardiac hypertrophy in AC16 cells by inhibiting the NF-kappaB signaling pathway. Wen J et al., 2020 Mar, Int J Mol MedRead more
- Postinfarction exercise training alleviates cardiac dysfunction and adverse remodeling via mitochondrial biogenesis and SIRT1/PGC-1alpha/PI3K/Akt signaling. Jia D et al., 2019 Dec, J Cell PhysiolRead more
- Gentisic acid prevents the transition from pressure overload-induced cardiac hypertrophy to heart failure. Sun S et al., 2019 Feb 28, Sci RepRead more
- Effects of anoxic exposure on the nuclear factor of activated T cell (NFAT) transcription factors in the stress-tolerant wood frog. Al-Attar R et al., 2018 Dec, Cell Biochem FunctRead more
- Hydrogen sulfide mitigates homocysteine-mediated pathological remodeling by inducing miR-133a in cardiomyocytes. Kesherwani V et al., 2015 Jun, Mol Cell BiochemRead more
- The regulation of troponins I, C and ANP by GATA4 and Nkx2-5 in heart of hibernating thirteen-lined ground squirrels, Ictidomys tridecemlineatus. Luu BE et al., 2015, PLoS OneRead more